Skip to main content
SeouLinBioscienceCO.,LTD. logo

SeouLinBioscienceCO.,LTD. — Investor Relations & Filings

Ticker · 038070 ISIN · KR7038070009 KO Professional, scientific and technical activities
Open in API
Filings indexed 209 across all filing types
Latest filing 2021-12-15 Regulatory Filings
Country KR South Korea
Listing KO 038070

About SeouLinBioscienceCO.,LTD.

SeouLin Bioscience is a total solutions provider for the life sciences and healthcare sectors, specializing in bio-research and production. Established in 1984, the company supplies a comprehensive range of research reagents, laboratory equipment, and materials. It also develops and manufactures specialized products, including Hypochlorous Acid (HOCl) sterilization water generators, DNA chip scanners, and diagnostic DNA kits. The company's research and development activities focus on creating novel diagnostic solutions, such as field kits for detecting marine viruses and pathogens related to food safety. SeouLin Bioscience aims to deliver integrated solutions that support scientific discovery and bioproduction processes.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement regarding the setting of a record date and the closure of the shareholder register for the purpose of holding an Annual General Meeting. It does not contain the full report or proxy materials, but rather serves as a formal notification of the upcoming meeting-related administrative action. Given the nature of the announcement and the lack of a specific category for 'Record Date/Shareholder Register' notices, it falls under the general regulatory filing category.
2021-12-15 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount Classification · 1% confidence The document is a short regulatory announcement regarding the closure of the shareholder register for the purpose of determining dividend eligibility and the upcoming Annual General Meeting. It does not contain the actual dividend amount or the full financial report, but rather announces the record date for these corporate actions. Given the nature of the announcement regarding shareholder rights and meeting preparation, it falls under general regulatory filings.
2021-12-15 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement regarding the completion of a private placement of convertible bonds (증권 발행결과). It details the issuance amount, payment date, and confirms the completion of the transaction. This falls under the category of capital and financing updates, specifically related to the issuance of debt instruments.
2021-11-24 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange regarding the decision to issue convertible bonds (전환사채권 발행결정). This type of filing is a regulatory disclosure concerning capital structure changes and financing activities. Under the provided categories, 'CAP' (Capital/Financing Update) is the most accurate classification for announcements regarding the issuance of convertible bonds, as it details the terms, purpose, and participants of the financing.
2021-11-22 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for Seoulin Bioscience Co., Ltd. covering the period from January 1, 2021, to September 30, 2021. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-11-15 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 1% confidence The document is a preliminary earnings release (영업(잠정)실적) for Seorin Bio Science for the third quarter of 2021. It provides key financial highlights such as revenue, operating profit, and net income in a tabular format, explicitly stating these are preliminary figures (잠정치) and not yet audited. This fits the definition of an Earnings Release (ER). 9M 2021
2021-10-27 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.